Voyageur Pharmaceuticals Ltd.
VYYRF
$0.1285
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.25M | 1.36M | 1.11M | 982.70K | 835.50K |
| Depreciation & Amortization | 1.00K | 1.10K | 1.20K | 1.30K | 1.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.26M | 1.36M | 1.11M | 984.00K | 836.90K |
| Operating Income | -1.26M | -1.36M | -1.11M | -984.00K | -836.90K |
| Income Before Tax | -1.55M | -1.58M | -1.25M | -1.13M | -962.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.55 | -1.58 | -1.25 | -1.13 | -0.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.55M | -1.58M | -1.25M | -1.13M | -962.00K |
| EBIT | -1.26M | -1.36M | -1.11M | -984.00K | -836.90K |
| EBITDA | -1.25M | -1.36M | -1.11M | -982.70K | -835.50K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 595.53M | 573.24M | 550.46M | 543.76M | 537.02M |
| Average Diluted Shares Outstanding | 595.53M | 573.24M | 550.46M | 543.76M | 537.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |